Replies to post #195905 on Biotech Values

[DewDiligence]

I do think PD-L1 status is more important for 1st line.

No question. The downside from making the wrong treatment decision and the upside from making the right treatment decision are greatly magnified in the first-line setting compared to subsequent lines of treatment.